Abstract
The X-linked PIG-A gene is involved in the biosynthesis of the cell surface anchor GPI, and its inactivation may serve as a new marker for mutagenicity. The in vivo PIG-A gene mutation assay is currently being validated by several groups. In this study, we established a corresponding in vitro variant of the PIG-A assay applying B-lymphoblastoid TK6 cells. PE-conjugated antibodies against the GPI-anchored proteins CD55 and CD59 were used to determine the GPI status via multicolor flow cytometry. Mutant spiked TK6 cell samples were analyzed, and mutants were quantified with even small numbers being quantitatively recovered. To validate our approach, mutant spiked cell samples were analyzed by flow cytometry and proaerolysin selection in parallel, yielding a high correlation. Further, we developed a procedure to reduce the background level of preexisting mutant cells to lower than 20 in 106 cells to increase the sensitivity of the assay. Spontaneous rate of GPI deficiency was investigated being 0.76 × 10−6/cell/generation for TK6 cells. The optimal phenotype expression time after ethyl methanesulfonate treatment was found to be 10 days. We applied the in vitro PIG-A assay to demonstrate the mutagenicity of ethyl methanesulfonate, 4-nitroquinoline 1-oxide and UV-C irradiation in a dose-dependent and statistically significant manner. Pyridine and cycloheximide were included as negative controls providing negative test results up to 10 mM. These data suggest that the in vitro PIG-A assay could complement the in vivo PIG-A assay with some distinct advantages compared to other in vitro mammalian mutagenicity tests.
Similar content being viewed by others
References
Abrami L et al (1998) The pore-forming toxin proaerolysin is activated by furin. J Biol Chem 273:32656–32661
Amundson SA, Liber HL (1991) A comparison of induced mutation at homologous alleles of the tk locus in human cells. Mutat Res Fund Mol Mech Mutagen 247:19–27
Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci 96:5209–5214
Araten D et al (2002) Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia 16:2243
Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, Notaro R, Luzzatto L (2005) A quantitative measurement of the human somatic mutation rate. Cancer Res 65:8111–8117
Araten DJ, Martinez-Climent JA, Perle MA, Holm E, Zamechek L, DiTata K, Sanders KJ (2010) A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene. Mutat Res Fund Mol Mech Mutagen 686:1–8
Beranek DT (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res Fund Mol Mech 231:11–30
Bessler M et al (1994) Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13:110
Bhalli JA, Shaddock JG, Pearce MG, Dobrovolsky VN, Cao X, Heflich RH, Vohr HW (2011) Report on stage III Pig-a mutation assays using benzo [a] pyrene. Environ Mol Mutagen 52:731–737
Bryce SM, Bemis JC, Dertinger SD (2008) In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen 49:256–264
Cammerer Z et al (2011) Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea—comparison with other in vivo genotoxicity endpoints. Environ Mol Mutagen 52:721–730
Dertinger SD et al (2011) International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories. Environ Mol Mutagen 52:690–698
Diep DB, Nelson KL, Raja SM, Pleshak EN, Buckley JT (1998) Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem 273:2355–2360
Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD (2010) The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ Mol Mutagen 51:825–835
Enninga IC, Groenendijk R, Filon A, Van Zeeland A, Simons J (1986) The wavelength dependence of UV-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts. Carcinogenesis 7:1829–1836
Fellows MD, McDermott A, Clare KR, Doherty A, Aardema MJ (2014) The spectral karyotype of L5178Y TK+/− mouse lymphoma cells clone 3.7. 2C and factors affecting mutant frequency at the thymidine kinase (tk) locus in the microtitre mouse lymphoma assay. Environ Mol Mutagen 55:35–42
Fetterhoff T, Holland S, Wile K (1993) Fluorescent detection of non-viable cells in fixed cell preparations. Cytometry 14:27
Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal Biochem 110:1–8
Fuscoe J, Ockey CH, Fox M (1986) Molecular analysis of X-ray-induced mutants at the HPRT locus in V79 Chinese hamster cells. Int J Radiat Biol 49:1011–1020
Glaab WE, Tindall KR (1997) Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 18:1–8
Green MH, O’Neill JP, Cole J (1995) Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat Res Environ Mutagen 334:323–339
Grosovsky AJ, Parks KK, Giver CR, Nelson SL (1996) Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol Cell Biol 16:6252–6262
Hillmen P, Bessler M, Mason PJ, Watkins WM, Luzzatto L (1993) Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci 90:5272–5276
Jacobson ED, Krell K, Dempsey MJ (1981) The wavelength dependence of ultraviolet light-induced cell killing and mutagenesis in L5178Y mouse lymphoma cells. J Photochem Photobiol 33:257–260
Jhappan C, Noonan FP, Merlino G (2003) Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22:3099–3112
Kirkland D, Aardema M, Henderson L, Müller L (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1
Kirkland D, Reeve L, Gatehouse D, Vanparys P (2011) A core in vitro genotoxicity battery comprising the ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res Genet Toxicol Environ 721:27–73
Kodama Y, Boreiko CJ, Skopek TR, Recio L (1989) Cytogenetic analysis of spontaneous and 2-cyanoethylene oxide-induced tk−/− mutants in TK6 human lymphoblastoid cultures. Environ Mol Mutagen 14:149–154
Koyama N et al (2006) Genotoxicity of acrylamide and glycidamide in human lymphoblastoid TK6 cells. Mutat Res Genet Toxicol Environ 603:151–158
Krawitz PM et al (2013) A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT. Blood 122:1312–1315
Luzzatto L (2013) PNH from mutations of another PIG gene. Blood 122:1099–1100
Miura D, Dobrovolsky VN, Mittelstaedt RA, Kasahara Y, Katsuura Y, Heflich RH (2008a) development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A Mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49:622–630
Miura D, Dorovolsky VN, Kasahara Y, Katsuura Y, Heflich RH (2008b) Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ Mol Mutagen 49:614–621
Miura D, Shaddock JG, Mittelstaedt RA, Dobrovolsky VN, Kimoto T, Kasahara Y, Heflich RH (2011) Analysis of mutations in the Pig-a gene of spleen T-cells from N-ethyl-N-nitrosourea-treated fisher 344 rats. Environ Mol Mutagen 52:419–423
Morris SM (2002) A role for p53 in the frequency and mechanism of mutation. Mutat Res Rev Mutat 511:45–62
Nakamura J, Gul H, Tian X, Bultman SJ, Swenberg JA (2012) Detection of PIGO-deficient cells using proaerolysin: a valuable tool to investigate mechanisms of mutagenesis in the DT40 cell system. PLoS ONE 7:e33563
OECD (1997) Organisation for economic co-operation and development (OECD). Test No. 476: in vitro mammalian cell gene mutation test
Parker MW, Van Der Goot FG, Buckley JT (2003) Aerolysin—The ins and outs of a model channel-forming toxin. Mol Microbiol 19:205–212
Parry JM, Parry EM (2012) Methods in molecular biology 817 (springer protocols)—Genetic toxicology: principles and methods. Humana Press, New York
Peruzzi B, Araten DJ, Notaro R, Luzzatto L (2010) The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutat Res Rev Mutat 705:3–10
Phonethepswath S, Bryce SM, Bemis JC, Dertinger SD (2008) Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. Mutat Res Genet Toxicol Environ 657:122–126
Phonethepswath S et al (2010) Pig-a Mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114:59–70
Rosti V, Tremml G, Soares V, Pandolfi PP, Luzzatto L, Bessler M (1997) Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest 100:1028
Rothfuss A et al (2011) Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing. Mutat Res 723:108–120
Ryu J-C et al (1999) Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic big blue rat2 cell line. Mutat Res Genet Toxicol Environ 445:127–135
Schneider-Poetsch T et al (2010) Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol 6:209–217
Schuler M, Gollapudi BB, Thybaud V, Kim JH (2011) Need and potential value of the Pig-a in vivo mutation assay—a hesi perspective. Environ Mol Mutagen 52:685–689
Steen AM, Meyer KG, Recio L (1997a) Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1, 2, 3, 4-diepoxybutane. Mutagenesis 12:61–67
Steen AM, Meyer KG, Recio L (1997b) Characterization of hprt mutations following l, 2-epoxy-3-butene exposure of human TK6 cells. Mutagenesis 12:359–364
Takeda J et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711
Van Zeeland A, Simons J (1976) Linear dose–response relationships after prolonged expression times in V-79 Chinese hamster cells. Mutat Res Fund Mol Mech 35:129–137
Zölzer F, Kiefer J (1984) Wavelength dependence of inactivation and mutation induction to 6-thioguanine-resistance in V79 Chinese hamster fibroblasts. J Photochem Photobiol 40:49–53
Acknowledgments
This study was financially supported by the Deutsche Forschungsgemeinschaft (Excellence Initiative KIT).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krüger, C.T., Hofmann, M. & Hartwig, A. The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells. Arch Toxicol 89, 2429–2443 (2015). https://doi.org/10.1007/s00204-014-1413-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-014-1413-5